Determining half-life of SARS-CoV-2 antigen in respiratory secretion

被引:3
|
作者
Guang, Yang [1 ]
Hui, Liu [1 ]
机构
[1] Dalian Med Univ, Dept Lab & Quarantine, Dalian, Peoples R China
关键词
SARS-CoV-2; COVID-19; Half-life; Environmental hygiene; CORONAVIRUS;
D O I
10.1007/s11356-023-27326-1
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is primarily transmitted from person to person through respiratory droplets and aerosols. It is also possible for the virus to be transmitted indirectly through environmental contamination. The likelihood of environmental transmission depends on several factors, including the survival time of the virus in respiratory secretions. However, the stability of SARS-CoV-2 in respiratory secretions has not been investigated. In this study, we compared the half-life of the SARS-CoV-2 antigen in respiratory secretion under different conditions. We applied respiratory secretion (5 mu L) to glass slides, air-dried the slides for 1 h, and kept them at 24 degrees C or 4 degrees C for 10 days. Respiratory secretions were also placed in test tubes (sealed to preserve moisture) and in normal saline for 10 days. The concentration of SARS-CoV-2 antigen in all samples was simultaneously measured using colloidal gold immunochromatography, and the half-life of the antigen was calculated. The half-life of the antigen in the wet (sealed tube) and saline samples at room temperature was 5.0 and 2.92 days, respectively. The half-life of the antigen in the air-dried sample at room temperature and at 4 degrees C was 2.93 and 11.4 days, respectively. The half-life was longer in respiratory secretions than that in normal saline. The half-life was also longer in respiratory secretions, at a lower temperature, and under wet conditions. Therefore, environmental transmission can also play a significant role in the spread of the virus. Robust prevention and control strategies could be developed based on the half-life of the antigen in respiratory secretions.
引用
收藏
页码:69697 / 69702
页数:6
相关论文
共 50 条
  • [31] There is no "origin" to SARS-CoV-2
    Frutos, Roger
    Pliez, Olivier
    Gavotte, Laurent
    Devaux, Christian A.
    ENVIRONMENTAL RESEARCH, 2022, 207
  • [32] Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2
    Riester, Elena
    Majchrzak, Mario
    Muehlbacher, Annelies
    Tinguely, Caroline
    Findeisen, Peter
    Hegel, Johannes Kolja
    Laimighofer, Michael
    Rank, Christopher M.
    Schoenfeld, Kathrin
    Langen, Florina
    Laengin, Tina
    Niederhauser, Christoph
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2381 - 2397
  • [33] Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2
    Elena Riester
    Mario Majchrzak
    Annelies Mühlbacher
    Caroline Tinguely
    Peter Findeisen
    Johannes Kolja Hegel
    Michael Laimighofer
    Christopher M. Rank
    Kathrin Schönfeld
    Florina Langen
    Tina Laengin
    Christoph Niederhauser
    Infectious Diseases and Therapy, 2021, 10 : 2381 - 2397
  • [34] Investigation of SARS-CoV-2 IgG Binding Capability to Variants of the SARS-CoV-2 Virus
    Johnson, Lucy
    De Gascun, Cillian F.
    Hassan, Jaythoon
    VIRAL IMMUNOLOGY, 2024, 37 (08) : 404 - 410
  • [35] Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting
    Leixner, Georg
    Voill-Glaninger, Astrid
    Bonner, Elisabeth
    Kreil, Anna
    Zadnikar, Rene
    Viveiros, Andre
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 108 : 353 - 356
  • [36] Complementarity determining regions in SARS-CoV-2 hybrid immunity
    Frans, Glynis
    Dillaerts, Doreen
    Dehaemers, Tom
    Van Elslande, Jan
    De Leeuw, Jonas
    Boon, Lise
    Maes, Wim
    Callewaert, Nico
    Calcoen, Bas
    Ancheva, Lina
    Cockx, Maaike
    Geukens, Nick
    Arat, Kusay
    Derua, Rita
    Vermeersch, Pieter
    Carpentier, Sebastien Christian
    Bossuyt, Xavier
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] Pooled SARS-CoV-2 antigen tests in asymptomatic children and their caregivers: Screening for SARS-CoV-2 in a pediatric emergency department
    Reichert, Friedrich
    Enninger, Axel
    Plecko, Thomas
    Zoller, Wolfram G.
    Paul, Gregor
    AMERICAN JOURNAL OF INFECTION CONTROL, 2021, 49 (10) : 1242 - 1246
  • [38] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
    Synowiec, Aleksandra
    Szczepanski, Artur
    Barreto-Duran, Emilia
    Lie, Laurensius Kevin
    Pyrc, Krzysztof
    CLINICAL MICROBIOLOGY REVIEWS, 2021, 34 (02) : 1 - 32
  • [39] Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2)
    Maveddat, Ashley
    Mallah, Haneen
    Rao, Sanjana
    Ali, Kiran
    Sherali, Samir
    Nugent, Kenneth
    INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2020, 11 (04) : 157 - 178
  • [40] Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs
    Aoki, Kotaro
    Nagasawa, Tatsuya
    Ishii, Yoshikazu
    Yagi, Shintaro
    Okuma, Sadatsugu
    Kashiwagi, Katsuhito
    Maeda, Tadashi
    Miyazaki, Taito
    Yoshizawa, Sadako
    Tateda, Kazuhiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (04) : 613 - 616